ENTRY       D03546                      Drug
NAME        Clofarabine (JAN/USAN/INN);
            Clolar (TN)
PRODUCT
  GENERIC   CLOFARABINE (Amneal Pharmaceuticals LLC)
            CLOFARABINE (Apotex Corp.)
            CLOFARABINE (Dr.Reddy's Laboratories)
            CLOFARABINE (Eugia US LLC)
            CLOFARABINE (Fosun Pharma USA)
            CLOFARABINE (Fresenius Kabi USA)
            CLOFARABINE (Gland Pharma Limited)
            CLOFARABINE (Meitheal Pharmaceuticals)
            CLOFARABINE (Mylan Institutional LLC)
            CLOFARABINE (Winthrop U.S.)
            CLOFARABINE (Zydus Lifesciences Limited)
FORMULA     C10H11ClFN5O3
EXACT_MASS  303.0534
MOL_WEIGHT  303.6774
CLASS       Antineoplastic
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
               DG01439  Arabinofuranosyl type antineoplastic
REMARK      Therapeutic category: 4229
            ATC code: L01BB06
            Product: D03546<JP/US>
EFFICACY    Antineoplastic, Antimetabolite
  DISEASE   Acute lymphoblastic leukemia [DS:H00001 H00002]
TARGET      RRM1 [HSA:6240] [KO:K10807]
            POLA [HSA:5422 23649] [KO:K02320 K02321]
  PATHWAY   hsa00230(6240)  Purine metabolism
            hsa00240(6240)  Pyrimidine metabolism
            hsa03030(23649+5422)  DNA replication
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BB Purine analogues
                 L01BB06 Clofarabine
                  D03546  Clofarabine (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antimetabolites
               Clofarabine
                D03546  Clofarabine (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               422  Antimetabolites
                4229  Others
                 D03546  Clofarabine (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG02018  Antimetabolite
               DG01958  Nucleic acid derivative, antineoplastic
                DG01439  Arabinofuranosyl type antineoplastic
                 D03546  Clofarabine
            Drug classes [BR:br08332]
             Antineoplastic
              DG02018  Antimetabolite
               D03546  Clofarabine
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Ribonucleoside-diphosphate reductase
                RRM1
                 D03546  Clofarabine (JAN/USAN/INN) &lt;JP/US&gt;
              Transferases (EC2)
               DNA polymerase
                POLA
                 D03546  Clofarabine (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03546
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03546
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03546
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03546
DBLINKS     CAS: 123318-82-1
            PubChem: 47205855
            ChEBI: 681569
            PDB-CCD: CFB
            LigandBox: D03546
            NIKKAJI: J457.798A
ATOM        20
            1   C1y C    23.0884  -19.5314
            2   C1y C    24.4740  -19.5314
            3   C1y C    24.9021  -18.2136
            4   O2x O    23.7812  -17.3992
            5   C1y C    22.6603  -18.2136
            6   N5x N    27.3020  -19.5991
            7   C8y C    27.3020  -18.2136
            8   N4y N    26.1021  -17.5208
            9   C1b C    21.4603  -17.5208
            10  O1a O    20.2604  -18.2136
            11  X   F    25.2884  -20.6523
            12  O1a O    22.2740  -20.6523
            13  C8y C    28.5019  -20.2919
            14  N5x N    29.7019  -19.5991
            15  C8y C    29.7019  -18.2136
            16  C8y C    28.5019  -17.5208
            17  C8x C    26.5178  -16.1371
            18  N5x N    28.0862  -16.1367
            19  X   Cl   28.5019  -21.6790
            20  N1a N    30.9035  -17.5196
BOND        22
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     6   7 1
            7     7   8 1
            8     3   8 1 #Up
            9     5   9 1 #Up
            10    9  10 1
            11    2  11 1 #Up
            12    1  12 1 #Down
            13    6  13 2
            14   13  14 1
            15   14  15 2
            16   15  16 1
            17    7  16 2
            18    8  17 1
            19   16  18 1
            20   17  18 2
            21   13  19 1
            22   15  20 1
///
